SKI Market

Indian Indices

Nifty

25,050.55 69.90
(0.28%)

Sensex

81,928.16 70.32
( 0.09%)

Bank Nifty

55,698.50 -166.65
( -0.30%)

Nifty IT

35,690.05 933.35
( 2.69%)

Global Indices

Nasdaq

44,950.40 7.12
(0.02%)

Dow Jones

6,415.95 -16.42
(-0.26%)

Hang Seng

42,914.69 -631.60
(-1.45%)

Nikkei 225

9,288.14 98.92
(1.08%)

Forex

USD-INR

87.11 -0.26
(-0.30%)

EUR-INR

101.58 -0.47
(-0.46%)

GBP-INR

117.61 -0.63
(-0.53%)

JPY-INR

0.59 0.00
(-0.35%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Albert David Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524075

INE155C01010

687.3663748

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALBERTDAVD

73.99

465.59

EPS(TTM)

Face Value()

Div & Yield %

11.02

0.61

Back

Timken India standalone net profit rises 8.21% in the June 2025 quarter

Aug 01,2025

Net profit of Timken India rose 8.21% to Rs 104.22 crore in the quarter ended June 2025 as against Rs 96.31 crore during the previous quarter ended June 2024. Sales rose 3.21% to Rs 808.82 crore in the quarter ended June 2025 as against Rs 783.70 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	808.82	783.70	3
OPM %	17.60	17.98	-
PBDT	151.23	151.73	0
PBT	130.43	129.83	0
NP	104.22	96.31	8

25,050.55 69.90 (0.28%)

81,928.16 70.32 ( 0.09%)

55,698.50 -166.65 ( -0.30%)

35,690.05 933.35 ( 2.69%)

44,950.40 7.12 (0.02%)

6,415.95 -16.42 (-0.26%)

42,914.69 -631.60 (-1.45%)

9,288.14 98.92 (1.08%)

87.11 -0.26 (-0.30%)

101.58 -0.47 (-0.46%)

117.61 -0.63 (-0.53%)

0.59 0.00 (-0.35%)